The hook effect in prolactin immunoassays

Saudi Medical Journal

Volumn 25, Issue 5, 2004, Pages 656-659

  Al Sifri, Saud N ^a   Raef, Hussein ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVOTHYROXINE; PROLACTIN;

ADULT; ARTICLE; CANCER INVASION; CANCER SURGERY; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; IMMUNOASSAY; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SELLA TURCICA TUMOR; STAINING; VISUAL DISORDER;

ADULT; ENDOSCOPY; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; HYPERPROLACTINEMIA; IMMUNOASSAY; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 2942683024     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Grebe SK, Delahunt JW, Feek CM. Treatment of extensively invasive (giant) prolactinomas with bromocriptine. N Z Med J 1992; 105: 129-131.
2. Perani D, Colombo N, Scotti G, Tonon C. Rapid size reduction of giant prolactinoma following medical treatment. J Comput Assist Tomogr 1984; 8:131-133.
3. Goel A, Nadkarni T. Surgical management of giant pituitary tumours: A review of 30 cases. Acta Neurochir (Wien) 1996; 138: 1042-1049.
4. Mohr G, Hardy J, Comtois R, Beauregard H. Surgical management of giant pituitary adenomas. Can J Neurol Sci 1990; 17: 62-66.
5. Scherrer H, Turpin G, De Gennes JL, Schaison-Cusin M, Hesmati HM, Thibierge M et al. Resultats du traitement par Bromocriptine des adenomes prolactine geants ou expansifs: A propos de 20 obsevations. Ann Med Interne (Paris) 1985; 136: 459-466.
6. Bevan JS, Burke CW, Esiri MM, Adams CB. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. Am J Med 1987; 82: 29-32.
7. Comtois R, Robert F, Hardy J. Immunoradiometric assays may miss high prolactin levels. Ann Intern Med 1993; 119: 173.
8. St-Jean E, Blain F, Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 1996; 44: 305-309.
9. Petakov MS, Damjanovic SS, Nikolic-Durovic MM, Dragojlovic ZL, Obradovic S, Gligorovic MS et al. Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays: the hook effect. J Endocrinol Invest 1998; 21: 184-188.
10. Cowden EA, Ratcliffe JG, Thomson JA, Macpherson P, Doyle D, Teasdale GM. Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 1979; 1: 1155-1158.
11. Klibanski A, Zervas NT. Diagnosis and management of hormon-secreting pituitary adenomas. N Engl J Med 1991; 324: 822-831.
12. Barkan AL, Chandler WF. Giant pituitary prolactinoma with falsely low serum prolactin: the pitfall of the "high-dose hook effect", case report (with discussion). Neurosurgery 1998; 42: 913-916.
13. Frieze TW, Mong DP, Koops MK. Hook effect in prolactinoma: case report and review of literature. Endocr Practice 2002; 8: 296-303.
14. Zweig MH, Csako G. High-dose hook effect in a two-site IRMA for measuring thyrotropin. Ann Clin Biochem 1990; 27: 494-495.
15. Wheeler CA, Davis S, Degefu S, Thorneycroft IH, O'Quinn AG. Ovarian choriocarcioma: A difficult diagnosis of an unusual tumor and a review of the hook effect. Obstet Gynecol 1990; 75: 547-549.
16. Saryan JA, Garrett PK, Kurtz SR. Failure to detect extremely high levels of serum IgE with an immunoradiometric assay. Ann Allergy 1989; 63: 322-324.
17. Dahlmann N, Brensing KA, Klingmuller D, Bidlingmaier F. "Hook-effect"in a patient with a gonadotropin-secreting tumor. Clin Chem 1990; 36: 168.
18. Wolf BA, Garrett NC, Nahm MH. The "hook effect": High concentrations of prostate-specific antigen giving artifactualy low values on one-step immunoassay. N Engl J Med 1989; 32: 1755-1756.
19. Haller BL, Fuller KA, Brown WS, Koenig JW, Eveland BJ, Scott MG. Two automated prolactin immunoassays evaluated with demonstration of a high-dose "hook effect" in one. Clin Chem 1992; 38: 437-438.
20. Mendes ABV, Vieira JGH, Kasamatsu T, Oliveira JHA, Abucham J. Falsely low prolactin values in hyperprolactinemic patients due to high dose hook effect. Proceedings of the 79th Annual Meeting of the Endocrine Society; 1997 June 11-14; Minneapolis, USA. p. 1-17.
21. Khosravi MJ. Shifting the hook effect in one-step immunometric assays. Clin Chem 1990; 36: 169-170.
22. Hoffman KL, Parsons GH, Allerdt LJ, Brooks JM, Miles LE. Elimination of hook effect in two site immunoradiometric assays by kinetic analysis. Clin Chem 1984; 30: 1499-1501.
23. Barbati A, Di Renzo GC, Cosmi EV. Hook effect in immunoradiometric assay of CA 125 in peritoneal fluid: evidence of high CA 125 concentrations by a comparative immunoblotting analysis. Clin Chem 1993; 39: 1547-1548.
24. Pesce MA. 'High-dose' hook effect with the centocor CA 125 assay. Clin Chem 1993; 39: 1347.